These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26543332)

  • 1. Circulating tumor cells isolation: the "post-EpCAM era".
    Raimondi C; Nicolazzo C; Gradilone A
    Chin J Cancer Res; 2015 Oct; 27(5):461-70. PubMed ID: 26543332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
    Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
    Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.
    Gabriel MT; Calleja LR; Chalopin A; Ory B; Heymann D
    Clin Chem; 2016 Apr; 62(4):571-81. PubMed ID: 26896446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system.
    Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y
    Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
    Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
    Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane Hsp70-A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition.
    Breuninger S; Stangl S; Werner C; Sievert W; Lobinger D; Foulds GA; Wagner S; Pickhard A; Piontek G; Kokowski K; Pockley AG; Multhoff G
    Front Oncol; 2018; 8():497. PubMed ID: 30443493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective Circulating Tumor Cell Isolation Using Epithelial and Mesenchymal Markers in Prostate and Pancreatic Cancer Patients.
    Cha J; Cho H; Chung JS; Park JS; Han KH
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EpCAM-expressing circulating tumor cells in colorectal cancer.
    Nicolazzo C; Raimondi C; Francescangeli F; Ceccarelli S; Trenta P; Magri V; Marchese C; Zeuner A; Gradilone A; Gazzaniga P
    Int J Biol Markers; 2017 Oct; 32(4):e415-e420. PubMed ID: 28604994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment, Isolation and Molecular Characterization of EpCAM-Negative Circulating Tumor Cells.
    Lampignano R; Schneck H; Neumann M; Fehm T; Neubauer H
    Adv Exp Med Biol; 2017; 994():181-203. PubMed ID: 28560675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
    Johnson ES; Anand RK; Chiu DT
    Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
    Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
    Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
    Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
    Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Optically Induced Dielectrophoresis (ODEP)-Based Microfluidic System for the Isolation of High-Purity CD45
    Liao CJ; Hsieh CH; Chiu TK; Zhu YX; Wang HM; Hung FC; Chou WP; Wu MH
    Micromachines (Basel); 2018 Oct; 9(11):. PubMed ID: 30715062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantified postsurgical small cell size CTCs and EpCAM
    Wang L; Li Y; Xu J; Zhang A; Wang X; Tang R; Zhang X; Yin H; Liu M; Wang DD; Lin PP; Shen L; Dong J
    Cancer Lett; 2018 Jan; 412():99-107. PubMed ID: 29031565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spiral shape microfluidic channel for selective isolating of heterogenic circulating tumor cells.
    Kwak B; Lee J; Lee J; Kim HS; Kang S; Lee Y
    Biosens Bioelectron; 2018 Mar; 101():311-316. PubMed ID: 29055574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles.
    Wang Z; Sun N; Liu H; Chen C; Ding P; Yue X; Zou H; Xing C; Pei R
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39586-39593. PubMed ID: 31577122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.